Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Nirogyone Therapeutics discloses MCT inhibitors

April 22, 2021

Dosing starts in phase I study of AL-102 in combination with WVT-078 in patients with MM

April 22, 2021

Aurigene CD73 inhibitor AU-21218 inhibits tumor growth in vivo

April 22, 2021

Phase I trials planned for new PARP1/2 inhibitor RP-12146

April 22, 2021

Brain-penetrant ALK inhibitor NUV-655 active against treatment-resistant mutations

April 22, 2021

Enrollment begins in phase I/II study of etrumadenant in metastatic colorectal cancer

April 22, 2021

Initiation of NOBLE Registry for Telix's TLX599-CDx SPECT in prostate cancer

April 21, 2021

New molecular imaging and therapy trials open at Hoag

April 21, 2021

Medshine Discovery patent describes LSD1 inhibitors

April 21, 2021

New GTPase KRAS mutant inhibitors presented by BeiGene

April 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...